NASDAQ: RGC
Regencell Bioscience Holdings Ltd Stock Ownership - Who owns Regencell Bioscience Holdings?

Insider buying vs selling

Have Regencell Bioscience Holdings Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RGC insiders and whales buy or sell their stock.

RGC Shareholders

What type of owners hold Regencell Bioscience Holdings Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Geode Capital Management LLC0.05%6,816$4.06MInstitution
Royal Bank Of Canada0.01%948$564.15kInstitution
Tower Research Capital LLC Trc0.01%698$415.38kInstitution
Blackrock Inc0.00%363$216.02kInstitution
Morgan Stanley0.00%5$2.98kInstitution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

RGC vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RGC0.07%0.00%
ELAN90.57%9.43%Net SellingNet Selling
LNTH56.27%43.73%Net SellingNet Selling
VTRS81.63%18.14%Net SellingNet Buying
ALKS93.22%6.78%Net SellingNet Selling

Regencell Bioscience Holdings Stock Ownership FAQ

Who owns Regencell Bioscience Holdings?

Regencell Bioscience Holdings (NASDAQ: RGC) is owned by 0.07% institutional shareholders, 0.00% Regencell Bioscience Holdings insiders, and 99.93% retail investors. Geode Capital Management LLC is the largest individual Regencell Bioscience Holdings shareholder, owning 6816.00 shares representing 0.05% of the company. Geode Capital Management LLC's Regencell Bioscience Holdings shares are currently valued at $4.06M.

If you're new to stock investing, here's how to buy Regencell Bioscience Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.